2,4-Diaminopteridine-Based Compounds as Precursors for De Novo Synthesis of Antifolates: a Novel Class of Antimalarials
暂无分享,去创建一个
[1] G. Hitchings,et al. Inhibition of folate biosynthesis and function as a basis for chemotherapy. , 1965, Advances in enzymology and related areas of molecular biology.
[2] S. Bushby. Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy. , 1969, Postgraduate medical journal.
[3] M. Berenbaum,et al. A method for testing for synergy with any number of agents. , 1978, The Journal of infectious diseases.
[4] J. Golenser,et al. Plasmodium falciparum: in vitro induction of resistance to aminopterin. , 1981, Experimental parasitology.
[5] W. Watkins,et al. In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors. , 1984, The American journal of tropical medicine and hygiene.
[6] W. Watkins,et al. Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. , 1985, Molecular and biochemical parasitology.
[7] J. Krungkrai,et al. De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum. , 1989, Molecular and biochemical parasitology.
[8] A. Cowman,et al. Chemotherapy and drug resistance in malaria. , 1990, International journal for parasitology.
[9] A. Rosowsky,et al. Synthesis and in vitro biological activity of new deaza analogues of folic acid, aminopterin, and methotrexate with an L-ornithine side chain. , 1991, Journal of medicinal chemistry.
[10] P. Hastings,et al. The phenotype of a dihydrofolate reductase mutant of Saccharomyces cerevisiae. , 1992, Gene.
[11] J. Bertino,et al. Karnofsky memorial lecture. Ode to methotrexate. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Curt,et al. Chemotherapy and drug resistance , 1994 .
[13] W. Sirawaraporn,et al. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. E. Hyde,et al. A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance , 1997, Parasitology.
[15] L. Hartwell,et al. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum. , 1997, Molecular and biochemical parasitology.
[16] C. Plowe,et al. The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. , 1997, Parasitology today.
[17] C. Sibley,et al. Yeast as a model system to study drugs effective against apicomplexan proteins. , 1997, Methods.
[18] D. Fidock,et al. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase. , 1998, Molecular pharmacology.
[19] J. Lunec,et al. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia. , 1999, Blood.
[21] R. Moran. Roles of folylpoly-gamma-glutamate synthetase in therapeutics with tetrahydrofolate antimetabolites: an overview. , 1999, Seminars in oncology.
[22] Mora Rg. Roles of folylpoly-gamma-glutamate synthetase in therapeutics with tetrahydrofolate antimetabolites: an overview. , 1999 .
[23] Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis? , 1999, The Biochemical journal.
[24] Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer. , 1999, Seminars in oncology.
[25] S. Gikunda,et al. In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania , 2000, Tropical medicine & international health : TM & IH.
[26] P. Winstanley. Chemotherapy for falciparum malaria: the armoury, the problems and the prospects. , 2000, Parasitology today.
[27] P. Adamson,et al. Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid. , 2000, The Journal of pharmacology and experimental therapeutics.
[28] A. Nzila,et al. Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum: Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites , 2000, Antimicrobial Agents and Chemotherapy.
[29] J. E. Hyde,et al. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? , 2001, Trends in parasitology.
[30] C. Sibley,et al. Efficacies of Lipophilic Inhibitors of Dihydrofolate Reductase against Parasitic Protozoa , 2001, Antimicrobial Agents and Chemotherapy.
[31] E. Nduati,et al. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania , 2001, The Lancet.
[32] J. E. Hyde,et al. Characterization of three genes encoding enzymes of the folate biosynthetic pathway in Plasmodium falciparum , 2001, Parasitology.
[33] P. Rosenthal,et al. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial , 2001, The Lancet.
[34] J. E. Hyde,et al. A bifunctional dihydrofolate synthetase--folylpolyglutamate synthetase in Plasmodium falciparum identified by functional complementation in yeast and bacteria. , 2001, Molecular and biochemical parasitology.
[35] I. Adagu,et al. Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[36] Yibin Zeng,et al. Synthesis of classical and nonclassical, partially restricted, linear, tricyclic 5-deaza antifolates. , 2002, Journal of medicinal chemistry.
[37] A. Nzila,et al. Sulfa drugs strike more than once. , 2004, Trends in parasitology.
[38] B. Bergmann,et al. Pyrimethamin-resistantPlasmodium falciparum lack cross-resistance to methotrexate and 2,4-diamino-5-(substituted benzyl) pyrimidines , 2004, Parasitology Research.